Massimo Fiandaca

Massimo Fiandaca

Executive Vice President, Therapeutic Strategies @ Asklepios BioPharmaceutical

About Massimo Fiandaca

Massimo Fiandaca serves as the Executive Vice President of Therapeutic Strategies at Asklepios BioPharmaceutical, Inc., focusing on AAV gene therapies for neurological disorders. He has held various academic and clinical positions, including roles at UC Irvine, Johns Hopkins Hospital, and the University of Maryland Medical System.

Current Role at Asklepios BioPharmaceutical

Massimo Fiandaca serves as the Executive Vice President of Therapeutic Strategies at Asklepios BioPharmaceutical, Inc. (AskBio) since 2020. His work focuses on developing AAV gene therapies specifically targeting Parkinson's disease and Multiple System Atrophy. He operates across multiple locations, including Castro Valley, CA; Columbus, OH; Warsaw, Poland; and RTP, NC. In this role, he engages in clinical trial planning and administration, ensuring the safety and efficacy of new therapeutic strategies.

Previous Academic Positions

Fiandaca held various academic positions prior to his current role. He was an Associate Professor in Residence at UC Irvine in the Departments of Neurology and Neurological Surgery from 2015 to 2019. He also served as an Associate Professor on the Research Track at Georgetown University Medical Center from 2012 to 2015. His experience includes teaching and conducting research in neurology and neurosurgery, contributing to advancements in the field.

Educational Background

Fiandaca's educational journey includes a Doctor of Medicine (M.D.) from Oregon Health & Science University, completed between 1977 and 1981. He also earned a Bachelor of Science (BS) in Zoology from Oregon State University, graduating cum laude in 1977. Additionally, he pursued an MBA in Business and Management at Loyola University Maryland from 1999 to 2001, enhancing his expertise in management within the healthcare sector.

Specialization and Research Focus

Fiandaca specializes in Convection Enhanced Delivery, a neurosurgical technique that allows for direct delivery of therapeutic agents to the brain. His research is centered on translational neuroscience, which applies findings from basic neuroscience research to develop new therapies for neurological disorders. He is involved in advancing neurosurgical methods that optimize safety, efficacy, and value in treating neurological conditions.

Professional Experience in Neurosurgery

Fiandaca has extensive experience in the field of neurosurgery. He worked as a Consultant Neurosurgeon for the Boston Red Sox in 1990-1991 and held various academic and clinical positions at institutions such as Johns Hopkins Hospital and the University of Maryland Medical System. His roles included Assistant Clinical Professor and Assistant Professor of Surgery, where he contributed to both clinical practice and education in neurosurgery.

People similar to Massimo Fiandaca